Serum cystatin C reflects the progress of albuminuria
- PMID: 22247903
- PMCID: PMC3253971
- DOI: 10.4093/dmj.2011.35.6.602
Serum cystatin C reflects the progress of albuminuria
Abstract
Background: Research on the relationship between urinary albumin excretion and serum cystatin C in diabetes is restricted to cross-sectional studies. In this study, we investigated how well serial measurements of serum cystatin C level reflect changes in the urinary albumin excretion rate.
Methods: We enrolled and retrospectively collected data on 1,058 participants with type 2 diabetes who were older than 18 years and who had more than 3 years of follow-up with serial measurements of albuminuria and serum cystatin C at an outpatient clinic.
Results: With the use of a linear mixed model, we found that the albuminuria level for each patient over time corresponded with the annual change in serum cystatin C-based estimated glomerular filtration rate (cysC-eGFR) but did not correspond with the creatinine-based eGFR calculated by the modification of diet in renal disease formula (MDRD-eGFR). The discrepancy in the direction of the trend was smaller with cysC-eGFR than with MDRD-eGFR.
Conclusion: Serum cystatin C level reflects the trend in albuminuria level more accurately than serum creatinine level in Korean type 2 diabetes mellitus patients.
Keywords: Albuminuria; Creatinine; Cystatin C; Diabetes mellitus, type 2; Diabetic nephropathies.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.J Korean Med Sci. 2011 Feb;26(2):258-63. doi: 10.3346/jkms.2011.26.2.258. Epub 2011 Jan 24. J Korean Med Sci. 2011. PMID: 21286018 Free PMC article.
-
Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients.Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102152. doi: 10.1016/j.dsx.2021.05.025. Epub 2021 May 25. Diabetes Metab Syndr. 2021. PMID: 34186366
-
Cystatin-C and TGF-β levels in patients with diabetic nephropathy.Nefrologia. 2016 Nov-Dec;36(6):653-659. doi: 10.1016/j.nefro.2016.06.011. Epub 2016 Oct 13. Nefrologia. 2016. PMID: 27745866 English, Spanish.
-
Diagnostic Performance of Cystatin C in the Early Detection of Diabetic Kidney Disease at the University of Nigeria Teaching Hospital, Ituku-Ozalla.Cureus. 2024 Oct 23;16(10):e72230. doi: 10.7759/cureus.72230. eCollection 2024 Oct. Cureus. 2024. PMID: 39502964 Free PMC article.
-
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17. Eur J Haematol. 2013. PMID: 23829647
Cited by
-
Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.Diabetes Metab J. 2021 Sep;45(5):698-707. doi: 10.4093/dmj.2020.0118. Epub 2021 Feb 2. Diabetes Metab J. 2021. PMID: 33517613 Free PMC article.
-
Lower Leg Fat Depots Are Associated with Albuminuria Independently of Obesity, Insulin Resistance, and Metabolic Syndrome (Korea National Health and Nutrition Examination Surveys 2008 to 2011).Diabetes Metab J. 2019 Aug;43(4):461-473. doi: 10.4093/dmj.2018.0081. Epub 2019 Mar 7. Diabetes Metab J. 2019. PMID: 30877714 Free PMC article.
References
-
- United States Renal Data System. USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
-
- de Boer IH, Steffes MW. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes. J Am Soc Nephrol. 2007;18:1036–1037. - PubMed
-
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266. - PubMed
-
- Gansevoort RT, de Jong PE. Challenges for the present CKD classification system. Curr Opin Nephrol Hypertens. 2010;19:308–314. - PubMed
-
- Viberti G, Walker JD. Natural history and pathogenesis of diabetic nephropathy. J Diabet Complications. 1991;5:72–75. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous